Robert I. Haddad, MD
Division of Head and Neck Oncology Dana-Farber Cancer Institute
Professor of medicine
Harvard Medical School
A new staging system for head and neck cancers recognizes that patients with oropharyngeal (OP) malignancies associated with the human papillomavirus (HPV) often have an excellent prognosis, but efforts to deintensify therapy for this population based on a fresh understanding of favorable risk factors may be premature.
... to read the full story